TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $135 Price Target
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsReiterationPrice TargetHot
TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintains $135 price target.
TD Cowen analyst Joshua Jennings reiterates Abbott Laboratories (NYSE:ABT) with a Buy and maintains $135 price target.